Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Clinical trial NCT01933334 · COMPLETED
Trial details
- NCT number
- NCT01933334
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-09-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.